Aim: To investigate sociodemographic and clinical-epidemiological profiles of patients with vulvar carcinoma in São Paulo, the largest city of Brazil, to establish a more consistent profile of these features once the incidence of vulvar carcinoma has risen considerably. Data regarding the epidemiological aspects of this tumor are scarce. Methods: A retrospective study was performed using 300 medical records from patients diagnosed with squamous cell carcinoma of the vulva and surgically treated at A.C. Camargo Hospital in São Paulo, Brazil, from 1978 to 2009. Results: The median age of onset was 70 years, ranging from 15 to 98 years, and most women were white (88.51%). Most patients (83.54%) had little or no schooling and had the lowest survival curve. Many patients were diagnosed in the early stages of the disease (57.09% FIGO IB), 59% had complications due to surgery and 43.71% had disease recurrence, of which about 70% died. Conclusions: Our study adds 300 Brazilian cases of vulvar carcinoma to the world literature. Given the high rate of disease recurrence and mortality in Brazil, we conclude that regular gynecologic evaluation and educational policies should be reinforced in order to raise awareness for vulvar cancer.

1.
Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics. CA Cancer J Clin 1998;48:6–29.
2.
Creasman WT, Phillips JL, Menck HR: The National Cancer Data Base report on early stage invasive vulvar carcinoma: the American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1997;80:505–513.
3.
Nogueira MC, Guedes Neto EP, Rosa MW, Zettler E, Zettler CG: Immunohistochemical expression of p16 and p53 in vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva. Pathol Oncol Res 2006;12:3.
4.
American Cancer Society: Cancer reference information, 2011. Retrieved August 1, 2012, from http://www.cancer.org.
5.
Messing MJ, Gallup DG: Carcinoma of the vulva in young women. Obstet Gynecol 1995;86:51–54.
6.
Joura EA, Losch A, Haider-Angeler MG, Breitenecker G, Leodolter S: Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med 2000;45:613–615.
7.
Lanneau GS, Argenta PA, Lanneau MS, Riffeburgh RH, Gold MA, McMeekin DS et al.: Vulvar cancer in young women: demographic features and outcome evaluation. Am J Obstet Gynecol 2009;200:645.
8.
Woelber L, Mahner S, Voelker K, Eulenburg CZ, Gieseking F, Choschzick M, et al: Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer. Anticancer Res 2009;29:545–552.
9.
Jones RW, Baranyai J, Stables S: Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia. Obstet Gynecol 1997;90:448–452.
10.
National Cancer Institute (NCI): Cancer Facts and Figures, 2005. Washington. Retrieved August 1, 2012, from http://www.cancer.gov/cancertopics/types/vulvar.
11.
International Agency for Research on Cancer (WHO): International Association of Cancer Registries (IARC): Cancer Incidence in Five Continents, Lyon, Scientific Publications, 1992, vol VI.
12.
Ministério da Saúde (Brasil): Instituto Nacional do Câncer (INCA) – Câncer no Brasil: Dados dos registros de Base populacional. Retrieved August 1, 2011, from http://www.inca.gov.br/estimativa/2012/index.asp?ID=5 [Portuguese].
13.
de Hullu JA, van der Avoort IA, Oonk MH, van der Zee AG: Management of vulvar cancers. Eur J Surg Oncol 2006;32:825–831.
14.
de Hullu JA, van der Zee AG: Surgery and radiotherapy in vulvar cancer. Crit Rev Oncol Hematol 2006;60:38–58.
15.
Dittmer C, Katalinic A, Mundhenke C, Thill M, Fischer D: Epidemiology of vulvar and vaginal cancer in Germany. Arch Gynecol Obstet 2011;284:169–174.
16.
Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA: Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol 2006;107:1018–1022.
17.
Hørding U, Junge J, Daugaard S, Lundvall F, Poulsen H, Bock JE: Vulvar squamosu cell carvinoma and papillomaviruses: indications for two different etiologies. Gynecol Oncol 1994;52: 241–246.
18.
Kumar S, Shah JP, Bryant CS, Imudia AN, Morris RT, Malone JM: A comparison of younger vs older women with vulvar cancer in the United States. Am J Obstet Gynecol 2009;200:52–55.
19.
Maggard MA, O’Connell JB, Lane KE, Liu JH, Etzioni DA, Ko CY: Do young breast cancer patients have worse outcomes? J Surg Res 2003;113:109–113.
20.
Pinto AP, Signorello LB, Crum CP, Harlow BL, Abrão F, Villa LL: Squamous cell carcinoma of the vulva in Brazil: prognostic importance of host and viral variables. Gynecol Oncol 1999;74:61–67.
21.
Saraiya M, Watson M, Wu X, King JB, Chen VW, Smith JS, Giuliano AR: Incidence of in situ and invasive vulvar cancer in the US, 1998–2003. Cancer 2008;15;113:2865–2872.
22.
Watson M, Saraiya M, Wu X: Update of HPV-associated female genital cancers in the United States, 1999–2004. J Womens Health 2009;18:1731–1738.
23.
Pena SD, Bastos-Rodrigues L, Pimenta JR, Bydlowski SP. DNA tests probe the genomic ancestry of Brazilians. Braz J Med Biol Res 2009;10:870–876.
24.
Joura EA, Leodolter S, Hernandez-Avila M, et al: Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 2007;369:1693–1702.
25.
Poppe W, Simon P, De Ridder M: Why consider human papillomavirus vaccination in older women? Gynecol Obstet Invest 2010;70:237–243.
26.
Saraiya M, Rosser JI, Cooper CP: Cancers that US physicians believe the HPV vaccine prevents: findings from a physician survey, 2009. J Womens Health (Larchmt) 2012;21:111–117.
27.
Villar LM, Rabello AD, de Paula VS: Evaluating knowledge about human papillomavirus infection among Brazilian health professionals. Asian Pac J Cancer Prev 2011;12:3251–3256.
28.
Knopp S, Tropè C, Nesland JM, Holm R: A review of molecular pathological markers in vulvar carcinoma: lack of application in clinical practice. J Clin Pathol 2009;62:212–218.
29.
Coulter J, Gleason N: Local and regional recurrence of vulval cancer: management dilemmas. Best Pract Res Clin Obstet Gynaecol 2003;17:663–681.
30.
Scheistrøen M, Nesland JM, Tropé C: Have patients with early squamous carcinoma of the vulva been overtreated in the past? The Norwegian experience 1977–1991. Eur J Gynaecol Oncol 2002;23:93–103.
31.
Ghurani GB, Penalver MA: An update on vulvar cancer. Am J Obstet Gynecol 2001;185:294–299.
32.
Maggino T, Landoni F, Sartori E, Zola P, Gadducci A, Alessi C, et al: Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF study. Cancer 2000;89:116–122.
33.
Piura B, Masotina A, Murdoch J Lopes A, Morgan P, Monaghan J: Recurrent squamous cell carcinoma of the vulva: a study of 73 cases. Gynecol Oncol 1993;48:189–195.
34.
Prempree T, Amornmarn R: Radiation treatment of recurrent carcinoma of the vulva. Cancer 1984;54:1943–1949.
35.
Brandenberger AW, Rudlinger R, Hanggi W, et al: Detection of human papillomavirus in vulvar carcinoma. A study by in situ hybridisation. Arch Gynecol Obstet 1992;252:31–35.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.